ClinVar Miner

Submissions for variant NM_203447.4(DOCK8):c.3254A>G (p.Asn1085Ser)

gnomAD frequency: 0.00002  dbSNP: rs527474230
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000358593 SCV000480268 uncertain significance Combined immunodeficiency due to DOCK8 deficiency 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003987524 SCV004803485 uncertain significance not specified 2024-01-16 criteria provided, single submitter clinical testing Variant summary: DOCK8 c.3254A>G (p.Asn1085Ser) results in a conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251332 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.3254A>G in individuals affected with Combined Immunodeficiency Due To DOCK8 Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 366972). Based on the evidence outlined above, the variant was classified as uncertain significance.
Ambry Genetics RCV004022120 SCV004859248 uncertain significance Inborn genetic diseases 2024-02-21 criteria provided, single submitter clinical testing The c.3254A>G (p.N1085S) alteration is located in exon 27 (coding exon 27) of the DOCK8 gene. This alteration results from a A to G substitution at nucleotide position 3254, causing the asparagine (N) at amino acid position 1085 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.